Banque Pictet & Cie Sa Viking Therapeutics, Inc. Transaction History
Banque Pictet & Cie Sa
- $12.3 Billion
- Q1 2025
A detailed history of Banque Pictet & Cie Sa transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 9,855 shares of VKTX stock, worth $263,621. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,855Holding current value
$263,621% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
463Shares Held
65.7MCall Options Held
5.8MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$272 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$161 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$132 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$69.4 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$57.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.05B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...